Meridian Bioscience (VIVO) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $3.57 +0.85%
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $46.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Healthcare Realty Trust (HR) Misses Q2 EPS by 12c
- Pinnacle Bank (PBNK) Tops Q2 EPS by 25c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
